For Andrew Hall, a veteran of Big Pharma-turned biotech builder, he has spent much of his recent career operating inside those constraints — and learning how to lead through them. Today, as CEO of ...

Current shareholders were thrown an unexpected curveball that they actually should have been expecting.

Some biotechs that had seen regulatory setbacks under Center for Biologics Evaluation and Research director Vinay Prasad experienced stock bumps Monday morning. Under Prasad’s leadership, the rare ...

This page contains press release content distributed by XPR Media. Members of the editorial and news staff of the USA TODAY Network were not involved in the creation of this content. The placement of ...

Rapid Micro Biosystems, Inc. sees strong FY25 revenue growth from Growth Direct placements, but losses persist. Click for ...

Shares end lower; Electro Optic Systems’ Middle East deal; Dalrymple Bay raises $350m; BHP’s fresh Chinese blow; Immutep ...

Solid Biosciences’ SGT-003 is the only late‑stage program to show early cardiac benefit across biomarkers and function, according to William Blair.

Bell Potter thinks this biotech could be working on something very big. The post Broker says this exciting ASX biotech stock could rise almost 50% appeared first on The Motley Fool Australia.

Live updates on markets and the top finance, economics and business stories. Plus the latest on oil prices, the Dow, S&P 500 and Nasdaq.

There are plenty of choices in the Sector - Health category, but where should you start your research? Well, one fund that might be worth investigating is ProFunds Biotech Ultra Sector Investor (BIPIX ...

While the treatment is primarily used for symptoms associated with menopause in women, it has also had its fair share of ...

"Physical AI agtech” could “draw a lot of capital and bring back 'tourist' VC," predicts Antony Yousefian at The First Thirty ...